This Project 1 proposal is part of a revised renewal application for the CORT Program entitled "Translating molecular signal pathways to orthopaedic trauma care". During the previous funding period, we published results contributing to the general hypothesis that inappropriate articular chondrocyte (AC) hypertrophy is a mechanism of OA pathogenesis. Given that PTH 1-34 (teriparatide) is an inhibitor of hypertrophy and inducer of matrix synthesis in chondrocytes, several of our recent breakthrough discoveries have solidified rationale for its use as a novel therapy for OA. Most important is our remarkable finding that teriparatide has dramatic chondro- regenerative effects in a mouse model of injury-induced knee OA. This is plausible mechanistically based on our published result that teriparatide induces the cyclinDI-dependent degradation of Runx2 in chondrocytes. Since Forteo (teriparatide) is already FDA-approved, and since patients enrolled in the NIH-sponsored OAI that were prescribed Forteo for osteoporosis had improved WOMAC knee function scores compared to matched controls, the rationale for clinical study is compelling. Based on this series of findings, we propose a continuation of this project that involves testing the following central hypotheses: The chondro-protective and -regenerative effect of teriparatide in murine posttraumatic OA involves stimulation of matrix production coupled with the inhibition of inappropriate articular chondrocytes maturation that is mechanistically linked to a reduction/inhibition of RUNX2. To address this hypothesis, we propose the following 3 Specific Aims: 1) To establish that the chondro-regenerative effects of teriparatide in posttraumatic knee OA are mediated by articular chondrocytes, 2) To characterize the molecular basis for the stimulation of matrix production and the inhibition of maturation induced by teriparatide in articular chondrocytes, and 3) To investigate the role of Jag1/Notch signaling in the effects of teriparatide on arthritic cartilage. If successful, completion of these aims will establish teriparatide as a candidate therapy for OA, a disease that currently is only treated palliatively.
The studies proposed in Project 1 aim to establish teriparatide as a therapy for osteoarthritis, a disease for which the current strategies for treatment are only palliative. Molecular mechanisms that underiie the cartilage regenerating effect of teriparatide will be comprehensively characterized with the aim of setting the stage for a future clinical study aimed at evaluating its chondro-regenerative potential in humans.
|Hamada, Daisuke; Maynard, Robert; Schott, Eric et al. (2016) Suppressive Effects of Insulin on Tumor Necrosis Factor-Dependent Early Osteoarthritic Changes Associated With Obesity and Type 2 Diabetes Mellitus. Arthritis Rheumatol 68:1392-402|
|Liu, Z; Ren, Y; Mirando, A J et al. (2016) Notch signaling in postnatal joint chondrocytes, but not subchondral osteoblasts, is required for articular cartilage and joint maintenance. Osteoarthritis Cartilage 24:740-51|
|Zhang, Yongchun; Sheu, Tzong-jen; Hoak, Donna et al. (2016) CCN1 Regulates Chondrocyte Maturation and Cartilage Development. J Bone Miner Res 31:549-59|
|Sheyn, Dmitriy; Shapiro, Galina; Tawackoli, Wafa et al. (2016) PTH Induces Systemically Administered Mesenchymal Stem Cells to Migrate to and Regenerate Spine Injuries. Mol Ther 24:318-30|
|Papuga, Mark O; Mesfin, Addisu; Molinari, Robert et al. (2016) Correlation of PROMIS Physical Function and Pain CAT Instruments With Oswestry Disability Index and Neck Disability Index in Spine Patients. Spine (Phila Pa 1976) 41:1153-9|
|de Mesy Bentley, Karen L; Trombetta, Ryan; Nishitani, Kohei et al. (2016) Evidence of Staphylococcus aureus Deformation, Proliferation and Migration in Canaliculi of Live Cortical Bone in Murine Models of Osteomyelitis. J Bone Miner Res :|
|Han, Songfeng; Proctor, Ashley R; Vella, Joseph B et al. (2016) Non-invasive diffuse correlation tomography reveals spatial and temporal blood flow differences in murine bone grafting approaches. Biomed Opt Express 7:3262-3279|
|Wang, Cuicui; Inzana, Jason A; Mirando, Anthony J et al. (2016) NOTCH signaling in skeletal progenitors is critical for fracture repair. J Clin Invest 126:1471-81|
|Zhang, Hengwei; Sun, Wen; Li, Xing et al. (2016) Use of Hes1-GFP reporter mice to assess activity of the Hes1 promoter in bone cells under chronic inflammation. Bone 90:80-9|
|Antebi, Ben; Zhang, Longze; Sheyn, Dmitriy et al. (2016) Controlling Arteriogenesis and Mast Cells Are Central to Bioengineering Solutions for Critical Bone Defect Repair Using Allografts. Bioengineering (Basel) 3:|
Showing the most recent 10 out of 118 publications